UROTHELIAL CARCINOMA
Clinical trials for UROTHELIAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new UROTHELIAL CARCINOMA trials appear
Sign up with your email to follow new studies for UROTHELIAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for tough bladder cancer: phase 3 trial launches for SYS6002
Disease control Not yet recruitingThis phase 3 trial tests a new drug called SYS6002 against standard chemotherapy in about 406 people with advanced bladder cancer that has not responded to platinum chemotherapy and immunotherapy. The main goal is to see if SYS6002 helps people live longer. The study is not yet r…
Matched conditions: UROTHELIAL CARCINOMA
Phase: PHASE3 • Sponsor: CSPC Megalith Biopharmaceutical Co.,Ltd. • Aim: Disease control
Last updated May 16, 2026 23:38 UTC
-
New hope for bladder cancer: maintenance drug aims to keep tumors at bay
Disease control Not yet recruitingThis study tests whether the drug avelumab can help keep advanced bladder cancer from getting worse after initial chemotherapy. About 144 people who have already received two prior treatments will receive avelumab as a maintenance therapy. The main goal is to see how long the can…
Matched conditions: UROTHELIAL CARCINOMA
Phase: PHASE2 • Sponsor: Gruppo Oncologico Italiano di Ricerca Clinica • Aim: Disease control
Last updated May 06, 2026 16:14 UTC
-
Massive bladder cancer study to reveal Real-World treatment outcomes
Knowledge-focused Not yet recruitingThis study will look at medical records from 3,000 adults with advanced bladder cancer to see how long their first treatment keeps the disease from getting worse. Researchers will also track which medicines doctors actually prescribe. This is not a new treatment trial—it simply o…
Matched conditions: UROTHELIAL CARCINOMA
Sponsor: Pfizer • Aim: Knowledge-focused
Last updated May 12, 2026 13:40 UTC